Mobia Medical is a commercial-stage medical device company focused on stroke rehabilitation. Its flagship Vivistim Paired VNS System pairs implanted vagus nerve stimulation with physical therapy to promote neuroplasticity and improve upper-limb function in chronic ischemic stroke survivors with moderate to severe impairment. It is positioned as an FDA-approved option for this niche and is sold mainly to U.S. stroke and rehabilitation centers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 5.7 | — | -10.7 | — |
| Q1 2026 | 12.1 | 113.3% | -17.7 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: TWFG, Inc. (TWFG), Century Therapeutics, Inc. (IPSC), Fortress Value Acquisition Corp. V (FVAV), American Battery Technology Company (ABAT), CURRENC Group Inc. (CURR), GSR V Acquisition Corp. (GSRV)